| Impact of anticholinergics on the aging brain: a review and practical application M Boustani, N Campbell, S Munger, I Maidment, C Fox Future Medicine Ltd 4 (3), 311-320, 2008 | 765 | 2008 |
| Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study C Fox, K Richardson, ID Maidment, GM Savva, FE Matthews, D Smithard, ... Journal of the American Geriatrics Society 59 (8), 1477-1483, 2011 | 725 | 2011 |
| The cognitive impact of anticholinergics: a clinical review N Campbell, M Boustani, T Limbil, C Ott, C Fox, I Maidment, CC Schubert, ... Clinical interventions in aging, 225-233, 2009 | 603 | 2009 |
| Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease M Rolinski, C Fox, I Maidment, R McShane Cochrane Database of Systematic Reviews, 2012 | 519 | 2012 |
| Anticholinergic drugs and risk of dementia: case-control study K Richardson, C Fox, I Maidment, N Steel, YK Loke, A Arthur, PK Myint, ... bmj 361, 2018 | 441 | 2018 |
| Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review C Fox, T Smith, I Maidment, WY Chan, N Bua, PK Myint, M Boustani, ... Age and ageing 43 (5), 604-615, 2014 | 366 | 2014 |
| Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis ID Maidment, CG Fox, M Boustani, J Rodriguez, RC Brown, CL Katona Annals of Pharmacotherapy 42 (1), 32-38, 2008 | 173 | 2008 |
| Cholinesterase inhibitors for Parkinson's disease dementia I Maidment, C Fox, M Boustani Cochrane Database of Systematic Reviews, 2006 | 169 | 2006 |
| Efficacy of memantine for agitation in Alzheimer’s dementia: a randomised double-blind placebo controlled trial C Fox, M Crugel, I Maidment, BH Auestad, S Coulton, A Treloar, C Ballard, ... PloS one 7 (5), e35185, 2012 | 167 | 2012 |
| The impact of anticholinergic burden in Alzheimer's dementia-the LASER-AD study C Fox, G Livingston, ID Maidment, S Coulton, DG Smithard, M Boustani, ... Age and ageing 40 (6), 730-735, 2011 | 120 | 2011 |
| The 2012 update to the anticholinergic cognitive burden scale NL Campbell, I Maidment, C Fox, B Khan, M Boustani Journal of the American Geriatrics Society 61 (S1), S142-S143, 2013 | 112 | 2013 |
| Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: a meta-analysis N Campbell, A Ayub, MA Boustani, C Fox, M Farlow, I Maidment, ... Clinical Interventions in Aging 3 (4), 719-728, 2008 | 107 | 2008 |
| Medication usage change in older people (65+) in England over 20 years: findings from CFAS I and CFAS II L Gao, I Maidment, FE Matthews, L Robinson, C Brayne, ... Age and ageing 47 (2), 220-225, 2018 | 97 | 2018 |
| Medication errors in mental healthcare: a systematic review ID Maidment, P Lelliott, C Paton BMJ Quality & Safety 15 (6), 409-413, 2006 | 96 | 2006 |
| A qualitative study exploring medication management in people with dementia living in the community and the potential role of the community pharmacist ID Maidment, L Aston, T Moutela, CG Fox, A Hilton Health Expectations 20 (5), 929-942, 2017 | 92 | 2017 |
| Use of medications with anticholinergic activity and self‐reported injurious falls in older community‐dwelling adults K Richardson, K Bennett, ID Maidment, C Fox, D Smithard, RA Kenny Journal of the American Geriatrics Society 63 (8), 1561-1569, 2015 | 89 | 2015 |
| Medication reconciliation by a pharmacy technician in a mental health assessment unit K Brownlie, C Schneider, R Culliford, C Fox, A Boukouvalas, C Willan, ... International journal of clinical pharmacy 36, 303-309, 2014 | 81 | 2014 |
| Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis NT Pieper, CM Grossi, WY Chan, YK Loke, GM Savva, C Haroulis, N Steel, ... Age and ageing 49 (6), 939-947, 2020 | 74 | 2020 |
| Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus … L Webster, D Groskreutz, A Grinbergs-Saull, R Howard, JT O’Brien, ... PLoS One 12 (6), e0179521, 2017 | 69 | 2017 |
| Glasgow antipsychotic side-effects scale for clozapine—development and validation of a clozapine-specific side-effects scale C Hynes, D Keating, S McWilliams, K Madigan, A Kinsella, I Maidment, ... Schizophrenia research 168 (1-2), 505-513, 2015 | 69 | 2015 |
Malaz BoustaniIndiana University School of MedicineVerified email at iu.edu
